In a lowlight enviroment heres a highlight. Not sure why the sustained downside. No change in sub holders?? Tax loss...who knows.
Based on the Company's net cash outlay expectations and allowing for an additional $15.0 million in
MRFF funds yet to be received plus the existing strong cash balance of $60.0 million, the Company has
a significant cash runway of at least seven quarters.
Ann: 4DMedical clinical trial results presented at ATS, page-64
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 4DX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
53.5¢ |
Change
0.005(0.94%) |
Mkt cap ! $219.6M | |||
| Open | High | Low | Value | Volume |
| 53.0¢ | 53.5¢ | 51.5¢ | $87.23K | 165.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1972 | 53.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 53.5¢ | 18244 | 1 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| 4DX (ASX) Chart |